Pharmaceutical
The latest news about Pharmaceutical: headlines, AI summaries and the full story from every source.
- BioMarin Incurs $283M IPR&D Expense Impacting Q3 Earnings
- GSK Aims for £40 Billion Sales Target with Oncology Growth and Cost-Saving Plan
- Innate Pharma Provides Q2 2026 Business Update and Financial Results
- Xenon Pharmaceuticals Downgraded by Deutsche Bank After Pausing Depression Trial Enrollment
- AbbVie's Reduced Commentary on Humira Amid Biosimilar Competition
- Kura Oncology Launches $50 Million Subsidiary to Advance Menin Inhibition Strategy in Diabetes
- Merck Shifts Focus from GARDASIL Decline to New Pipeline Opportunities
- BioMarin to Present at Multiple Investor Conferences in September
- BioMarin Acquires Alesta Therapeutics for $275 Million
- Argenx Agrees to Acquire Forte Biosciences in $2.2 Billion Deal
- argenx Acquires Forte Biosciences for $2.2 Billion to Expand Autoimmune Drug Portfolio
- West Pharmaceutical Services Reports Strong Q2 Results and Raises Full-Year Guidance
- Novo Nordisk Sues Eli Lilly Over GLP-1 Drug Advertising Claims
- Novartis Reports Q2 Sales Growth and Reaffirms Full-Year Outlook
- Bausch Health's Canadian Subsidiary Lists PrOKEDI Dosages in RAMQ Formulary
- Agios Pharmaceuticals Stock Rises on FDA Priority Review for Mitapivat in Sickle Cell Disease
- Innoviva Launches Nortiva Bio to Develop Long-Acting Oral Drug Platform
- Altaris to Acquire Simulations Plus in $375M All-Cash Deal
- Abivax Shares Plummet After Cancer Cases Emerge in Phase 3 Trial for Ulcerative Colitis Drug
- Eli Lilly Files Lawsuit Accusing Bishops and Organizations of $200M Trulicity Rebate Fraud
- Madrigal Pharmaceuticals Reports Strong Q1 2026 Performance with Rezdiffra's Blockbuster Sales
- BioCryst Pharmaceuticals Reports Q1 Earnings with Strong ORLADEYO Performance
- Cardinal Health Reports Q3 2026 Earnings with Revenue Growth and Operational Improvements
- Organon Shares Rise Following Sun Pharma's Acquisition Agreement
- Asahi Kasei Acquires German Biopharmaceutical Company Aicuris
- Eli Lilly to Acquire Cancer Biotech Kelonia for Up to $7 Billion
- Collegium Pharmaceutical Announces 2026 Revenue Outlook and $650M AZSTARYS Acquisition